Académique Documents
Professionnel Documents
Culture Documents
www.elsevier.es/medicinaclinica
Diagnostico y tratamiento
Como citar este artculo: Dez Morrondo C, Pantoja Zarza L. Aspectos actuales de la enfermedad de Still del adulto. Med Clin (Barc). 2013.
http://dx.doi.org/10.1016/j.medcli.2013.06.001
G Model
Tabla 1
Principales criterios de clasicacion de la enfermedad de Still del adulto
Criterios mayores
Yamaguchi
Fiebre > 39 8C, mas de una semana
Artralgias durante 2 o mas semanas
Erupcion tpica
Leucocitosis (> 10.000/mm3)
PMN > 80%
Niveles de ferritina elevados
Cush
Fiebre > 39 8C
Artralgias o artritis
Factor reumatoide < 1:80
ANA < 1:100
Fautrel
Fiebre en picos, superior a 39 8C
Artralgias
Eritema transitorio
Faringitis
PMN > 80%
Ferritina glucosilada < 20%
Criterios menores
Odinofagia
Adenopatas y/o esplenomegalia
Disfuncion hepatica
Factor reumatoide y ANA negativos
Brote maculopapular
Leucocitosis (> 10.000/mm3)
Como citar este artculo: Dez Morrondo C, Pantoja Zarza L. Aspectos actuales de la enfermedad de Still del adulto. Med Clin (Barc). 2013.
http://dx.doi.org/10.1016/j.medcli.2013.06.001
G Model
Tabla 2
Diagnostico diferencial de la enfermedad de Still del adulto con otras enfermedades
Infecciosas
Oncologicas o hematologicas
Sistemicas
Sepsis bacteriana
Endocarditis infecciosa
Infeccion oculta
Brucelosis
Tuberculosis
Yersinia
Hepatitis viral
Linfoma
Trastornos mieloproliferativos
Sndrome paraneoplasico
on, pulmon, colon)
Tumores de organos solidos (rin
Poliarteritis nudosa
Otras vasculitis
Polimiositis
Dermatomiositis
Lupus eritematoso sistemico
Artritis cronica seronegativa
Sndrome de Sweet
Enfermedad de Whipple
Sarcoidosis
Toxicodermia medicamentosa
Artritis reactiva o postestreptococica
Sndromes hereditarios autoinamatorios
Como citar este artculo: Dez Morrondo C, Pantoja Zarza L. Aspectos actuales de la enfermedad de Still del adulto. Med Clin (Barc). 2013.
http://dx.doi.org/10.1016/j.medcli.2013.06.001
G Model
18. Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, et al.
Etanercept in the treatment of adult patients with Stills disease. Arthritis
Rheum. 2002;46:11716.
19. Benucci M, Li GF, del Rosso A, Manfredi M. Adalimumab (anti-TNF-alpha)
therapy to improve the clinical course of adult-onset Stills disease: The rst
case report. Clin Exp Rheumatol. 2005;23:733.
20. Fautrel B, Sibilia J, Mariette X, Combe B, Club Rhumatismes et Inammation.
Tumour necrosis factor alpha blocking agents in refractory adult Stills
disease: An observational study of 20 cases. Ann Rheum Dis. 2005;64:
2626.
21. Suematsu R, Ohta A, Matsuura E, Takahashi H, Fujii T, Horiuchi T, et al.
Therapeutic response of patients with adult Stills disease to biologic agents:
Multicenter results in Japan. Mod Rheumatol. 2012;22:7129.
22. Bartoloni E, Alunno A, Luccioli F, Santoboni G, Gerli R. Successful treatment of
refractory adult-onset Stills disease with anti-CD20 monoclonal antibody. Clin
Exp Rheumatol. 2009;27:8889.
23. Ostrowski RA, Tehrani R, Kadanoff R. Refractory adult-onset still disease
successfully treated with abatacept. J Clin Rheumatol. 2011;17:3157.
24. Lopez R, Estrada S, Cervera R, Espinosa G. Ecacia del tocilizumab en la
enfermedad de Still del adulto. Med Clin (Barc). 2012;138:423.
25. Perdan-Pirkmajer K, Praprotnik S, Tomsic M. A case of refractory adult-onset
Stills disease successfully controlled with tocilizumab and a review of the
literature. Clin Rheumatol. 2010;29:14657.
26. Sabnis GR, Gokhale YA, Kulkarni UP. Tocilizumab in refractory adult-onset
Stills disease with aseptic meningitisEfcacy of interleukin-6 blockade and
review of the literature. Semin Arthritis Rheum. 2011;40:3658.
27. Kishida D, Okuda Y, Onishi M, Takebayashi M, Matoba K, Jouyama K, et al.
Successful tocilizumab treatment in a patient with adult-onset Stills disease
complicated by chronic active hepatitis B and amyloid A amyloidosis. Mod
Rheumatol. 2011;21:2158.
28. Yoshimura M, Makiyama J, Koga T, Miyashita T, Izumi Y, Torigoshi T, et al.
Successful treatment with tocilizumab in a patient with refractory adult-onset
Stills disease (AOSD). Clin Exp Rheumatol. 2010;28:1412.
29. Sakai R, Nagasawa H, Nishi E, Okuyama A, Takei H, Kurasawa T, et al. Successful
treatment of adult-onset Stills disease with tocilizumab monotherapy: Two
case reports and literature review. Clin Rheumatol. 2012;31:56974.
30. Tejera B, Martnez-Morillo M, Riveros A, Olive A. Enfermedad de Still del adulto:
tratamiento con farmacos biologicos en casos resistentes. Med Clin (Barc).
2012;140:3812.
31. Guignard S, Dien G, Dougados M. Severe systemic inammatory response
syndrome in a patient with adult onset Stills disease treated with the antiIL1 drug anakinra: A case report. Clin Exp Rheumatol. 2007;25:7589.
32. Kotter I, Wacker A, Koch S, Henes J, Richter C, Engel A, et al. Anakinra in patients
with treatment-resistant adult-onset Stills disease: Four case reports with
serial cytokine measurements and a review of the literature. Semin Arthritis
Rheum. 2007;37:18999.
33. Lequerre T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, et al.
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: Preliminary experience in France. Ann Rheum Dis. 2008;67:3028.
34. Nordstrom D, Knight A, Luukkainen R, van Vollenhoven R, Rantalaiho V,
Kajalainen A, et al. Benecial effect of interleukin 1 inhibition with anakinra
in adult-onset Stills disease. An open, randomized, multicenter study. J Rheumatol. 2012;39:10.
35. Fischer-Betz R, Specker C, Schneider M. Successful outcome of two pregnancies
in patients with adult-onset Stills disease treated with IL-1 receptor antagonist
(anakinra). Clin Exp Rheumatol. 2011;29:10213.
36. Kontzias A, Efthimiou P. The use of canakinumab, a novel IL-1b long-acting
inhibitor, in refractory adult-onset Stills disease. Semin Arthritis Rheum.
2012;42:2015.
Como citar este artculo: Dez Morrondo C, Pantoja Zarza L. Aspectos actuales de la enfermedad de Still del adulto. Med Clin (Barc). 2013.
http://dx.doi.org/10.1016/j.medcli.2013.06.001